Consult
Log In
Menu
Consult
Log in

by Josh Forsythe, on March 22, 2016

ST LOUIS, MO – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced that Bryan J. Carey and Frederick A. Hessler have been appointed to the company’s Board of Directors.

Read Story
Topics:News
Content not found